Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.
SZSE:300313.SZ
12.41 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 137.5 | 76.35 | 107.976 | 163.309 | 229.006 | 105.226 | 195.306 | 375.207 | 246.868 | 121.943 | 82.657 | 82.003 | 75.485 | 52.518 | 33.707 | 22.304 |
| Cost of Revenue
| 114.144 | 65.534 | 100.322 | 137.552 | 201.9 | 78.574 | 115.125 | 379.479 | 197.233 | 76.49 | 45.848 | 47.562 | 33.053 | 20.674 | 15.188 | 9.434 |
| Gross Profit
| 23.356 | 10.816 | 7.654 | 25.758 | 27.105 | 26.652 | 80.181 | -4.272 | 49.635 | 45.453 | 36.809 | 34.441 | 42.432 | 31.844 | 18.518 | 12.871 |
| Gross Profit Ratio
| 0.17 | 0.142 | 0.071 | 0.158 | 0.118 | 0.253 | 0.411 | -0.011 | 0.201 | 0.373 | 0.445 | 0.42 | 0.562 | 0.606 | 0.549 | 0.577 |
| Reseach & Development Expenses
| 1.639 | 0.565 | 1.515 | 0.764 | 2.102 | 1.288 | 1.693 | 4.94 | 3.522 | 3.031 | 2.084 | 0.898 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 5.68 | 3.788 | 6.088 | 4.863 | 21.412 | 19.403 | 14.851 | 28.187 | 17.318 | 13.19 | 8.979 | 7.159 | 5.994 | 2.662 | 2.524 | 0.765 |
| Selling & Marketing Expenses
| 4.461 | 3.249 | 3.294 | 4.674 | 6.49 | 6 | 10.686 | 26.995 | 22.296 | 14.43 | 11.194 | 7.616 | 3.606 | 1.505 | 1.911 | 6.033 |
| SG&A
| 10.141 | 7.036 | 9.382 | 9.536 | 27.903 | 25.402 | 25.537 | 55.182 | 39.614 | 27.62 | 20.173 | 14.775 | 9.6 | 4.166 | 4.435 | 6.799 |
| Other Expenses
| -0.645 | 9.377 | 12.46 | 16.971 | 14.99 | -102.97 | -0.087 | 6.448 | 4.837 | 6.002 | 4.666 | 6.365 | 8.041 | 4.074 | 1.257 | 2.764 |
| Operating Expenses
| 24.66 | 16.979 | 23.357 | 27.271 | 44.994 | 48.143 | 47.314 | 94.317 | 65.912 | 45.021 | 32.854 | 22.986 | 15.524 | 9.107 | 6.909 | 7.967 |
| Operating Income
| -18.661 | -6.163 | -15.703 | 17.933 | 17.158 | -1,842.63 | 11.166 | -187.595 | -48.766 | -0.372 | 8.8 | 12.757 | 23.525 | 21.05 | 11.153 | 3.333 |
| Operating Income Ratio
| -0.136 | -0.081 | -0.145 | 0.11 | 0.075 | -17.511 | 0.057 | -0.5 | -0.198 | -0.003 | 0.106 | 0.156 | 0.312 | 0.401 | 0.331 | 0.149 |
| Total Other Income Expenses Net
| -0.645 | -24.309 | -12.844 | -14.621 | -76.763 | -102.97 | -0.087 | 0.872 | 1.918 | 4.293 | 2.133 | 6.587 | 3.797 | 1.39 | -0.715 | 1.909 |
| Income Before Tax
| -19.306 | -30.472 | -28.547 | 3.312 | -59.605 | -1,945.6 | 11.079 | -186.723 | -46.848 | 3.921 | 10.933 | 19.344 | 27.322 | 22.44 | 10.438 | 5.242 |
| Income Before Tax Ratio
| -0.14 | -0.399 | -0.264 | 0.02 | -0.26 | -18.49 | 0.057 | -0.498 | -0.19 | 0.032 | 0.132 | 0.236 | 0.362 | 0.427 | 0.31 | 0.235 |
| Income Tax Expense
| 2.777 | 1.575 | 1.848 | 0.8 | 0.449 | 0.882 | 4.671 | -3.305 | 0.651 | 1.814 | 0.777 | 0.263 | 0.297 | 4.607 | 0.022 | 0.129 |
| Net Income
| -22.002 | -32.046 | -30.395 | 2.512 | -60.054 | -1,945.744 | 7.444 | -139.63 | -35.66 | 1.791 | 9.616 | 19.065 | 27.025 | 22.44 | 10.416 | 5.113 |
| Net Income Ratio
| -0.16 | -0.42 | -0.281 | 0.015 | -0.262 | -18.491 | 0.038 | -0.372 | -0.144 | 0.015 | 0.116 | 0.232 | 0.358 | 0.427 | 0.309 | 0.229 |
| EPS
| -0.07 | -0.1 | -0.097 | 0.008 | -0.19 | -7.09 | 0.04 | -0.72 | -0.2 | 0.01 | 0.053 | 0.11 | 0.2 | 0.16 | 0.095 | 0.071 |
| EPS Diluted
| -0.07 | -0.1 | -0.097 | 0.008 | -0.19 | -7.09 | 0.04 | -0.72 | -0.2 | 0.01 | 0.053 | 0.11 | 0.2 | 0.16 | 0.095 | 0.071 |
| EBITDA
| 15.091 | -2.246 | -0.688 | 35.291 | 41.058 | -98.598 | 57.67 | -58.951 | 1.839 | 25.05 | 26.689 | 33.092 | 40.684 | 32.701 | 19.215 | 11.356 |
| EBITDA Ratio
| 0.11 | -0.029 | -0.006 | 0.216 | 0.179 | -0.937 | 0.295 | -0.157 | 0.007 | 0.205 | 0.323 | 0.404 | 0.539 | 0.623 | 0.57 | 0.509 |